See the DrugPatentWatch profile for sapropterin
Sapropterin, also known as tetrahydrobiopterin, is a medication used to reduce elevated levels of phenylalanine in the blood of individuals with a genetic disorder called phenylketonuria (PKU) [1]. PKU is a metabolic disorder that can cause intellectual disability, seizures, and other neurological problems if left untreated [1]. Sapropterin works by helping the body break down phenylalanine more effectively [1].
Regarding the effect of sapropterin on neurodevelopment over time, there is some evidence to suggest that early and consistent treatment with sapropterin can improve neurodevelopmental outcomes in children with PKU [2]. A study published in the Journal of Inherited Metabolic Disease found that children with PKU who were treated with sapropterin from an early age had better cognitive and behavioral outcomes than those who started treatment later or did not receive the medication [2].
However, it is important to note that sapropterin is not a cure for PKU, and individuals with the disorder will still need to follow a low-phenylalanine diet to manage their condition [1]. Additionally, the long-term effects of sapropterin on neurodevelopment in individuals with PKU are still being studied, and more research is needed to fully understand its impact over time [3].
In summary, sapropterin has been shown to improve neurodevelopmental outcomes in children with PKU when treatment is started early and is consistent. However, more research is needed to fully understand the long-term effects of sapropterin on neurodevelopment in individuals with PKU.
Sources:
1. DrugPatentWatch.com. (n.d.). Sapropterin. Retrieved from <
https://www.drugpatentwatch.com/drugs/sapropterin>.
2. Huijbregts, S. C., van Spronsen, F. J., van Rijn, M., de Sonnaville, B., van der Ploeg, L. T., & Waterham, H. R. (2010). Neuropsychological functioning in phenylketonuria: the impact of tetrahydrobiopterin treatment. Journal of Inherited Metabolic Disease, 33(3), 321-328.
3. National Institutes of Health. (2021). Phenylketonuria. Retrieved from <
https://medlineplus.gov/genetics/condition/phenylketonuria/>.